Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction (Q37273987)

19 August 2017

Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction (English)

1 reference

19 August 2017

myocardial infarction

1 reference

12

Harlan M Krumholz

1 reference

19 August 2017

Paul Frederick

11

0 references

Eric D. Peterson

9

object named as

Eric D Peterson

1 reference

19 August 2017

Robert L McNamara

1

1 reference

19 August 2017

Jeph Herrin

2

1 reference

19 August 2017

Yongfei Wang

3

1 reference

19 August 2017

Jeptha P Curtis

4

1 reference

19 August 2017

Elizabeth H Bradley

5

1 reference

19 August 2017

David J Magid

6

1 reference

19 August 2017

Saif S Rathore

7

1 reference

19 August 2017

Brahmajee K Nallamothu

8

1 reference

19 August 2017

Martha E Blaney

10

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

American Journal of Cardiology

19 August 2017

1 reference

19 August 2017

100

1 reference

19 August 2017

8

1 reference

19 August 2017

1227-1232

1 reference

Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the M

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Trends in acute myocardial infarction management: use of the National Registry ofMyocardial Infarction in quality improvement

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715362

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

3 September 2018

1 reference

12 December 2020

ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction

1 reference

12 December 2020

Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: Analysis of the Cooperative Cardiovascular Project

1 reference

12 December 2020

Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

1 reference

12 December 2020

Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction

1 reference

12 December 2020

Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

10.1016/J.AMJCARD.2007.05.043

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

17920362

1 reference